Merck KGaA
MKGAF
$163.71
-$4.70-2.79%
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 5.29% | -3.58% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 5.29% | -3.58% | |||
| Cost of Revenue | 9.05% | -7.51% | |||
| Gross Profit | 2.76% | -0.74% | |||
| SG&A Expenses | 2.61% | -2.50% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 459.33% | 10.49% | |||
| Total Operating Expenses | 10.91% | -4.26% | |||
| Operating Income | -19.92% | -0.42% | |||
| Income Before Tax | -26.71% | 113.56% | |||
| Income Tax Expenses | -27.38% | 156.06% | |||
| Earnings from Continuing Operations | -26.51% | 103.46% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 57.22% | -83.36% | |||
| Net Income | -26.08% | 103.78% | |||
| EBIT | -19.92% | -0.42% | |||
| EBITDA | -12.43% | 7.02% | |||
| EPS Basic | -26.04% | 104.23% | |||
| Normalized Basic EPS | -26.05% | -23.14% | |||
| EPS Diluted | -26.04% | 104.23% | |||
| Normalized Diluted EPS | -26.05% | -23.14% | |||
| Average Basic Shares Outstanding | -0.04% | -0.23% | |||
| Average Diluted Shares Outstanding | -0.04% | -0.23% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | 100.33% | -- | |||